The safety of incretin based drug treatments for type 2 diabetes

Affiliations

¹ Division of General Internal Medicine, Department of Medicine, The MetroHealth System/Case Western Reserve University, Cleveland, OH, USA Department of Epidemiology and Biostatistics, Case Western Reserve University sdb73@case.edu.
² Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, MD, USA.

Editorial

Shari D Bolen et al. BMJ. 2016.

. 2016 Feb 17:352:i801.

doi: 10.1136/bmj.i801.

¹ Division of General Internal Medicine, Department of Medicine, The MetroHealth System/Case Western Reserve University, Cleveland, OH, USA Department of Epidemiology and Biostatistics, Case Western Reserve University sdb73@case.edu.
² Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, MD, USA.

No abstract available

Comment on

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.
Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Juurlink DN, Targownik LE, Turin TC, Paterson JM, Ernst P; Canadian Network for Observational Drug Effect Studies Investigators. Azoulay L, et al. BMJ. 2016 Feb 17;352:i581. doi: 10.1136/bmj.i581. BMJ. 2016. PMID: 26888382 Free PMC article.
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.
Li L, Li S, Deng K, Liu J, Vandvik PO, Zhao P, Zhang L, Shen J, Bala MM, Sohani ZN, Wong E, Busse JW, Ebrahim S, Malaga G, Rios LP, Wang Y, Chen Q, Guyatt GH, Sun X. Li L, et al. BMJ. 2016 Feb 17;352:i610. doi: 10.1136/bmj.i610. BMJ. 2016. PMID: 26888822 Free PMC article.